Malwina Rybicka-Ramos

A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

E. Ziv, N. Camp, C. Vachon, 2022, International journal of cancer.

Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation

A. Suszka-Świtek, R. Wiaderkiewicz, S. Mizia, 2022, World journal of biological chemistry.

Proinflammatory cytokines as potential risk factors of acute graft-versus-host disease and infectious complications after allogeneic hematopoietic stem cell transplantation.

A. Suszka-Świtek, R. Wiaderkiewicz, S. Mizia, 2021, American journal of blood research.

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

Abhishek Kumar, E. Ziv, N. Camp, 2023, International journal of molecular sciences.

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium

D. Campa, F. Canzian, J. Zaucha, 2019, Leukemia & lymphoma.

Identification of novel genetic loci for risk of multiple myeloma by functional annotation

E. Ziv, C. Vachon, S. Chanock, 2023, Leukemia.